Aripiprazole-related hyponatremia and consequent valproic acid-related hyperammonemia in one patient.
1 Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Beitou Branch, Taipei, Taiwan (ROC).|2 Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan (ROC).
Ming-Wei
MW
Lin
2 Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan (ROC).
Chieh
C
Chang
2 Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan (ROC).
Chin-Bin
CB
Yeh
1 Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Beitou Branch, Taipei, Taiwan (ROC).|2 Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan (ROC).
Yueh-Ming
YM
Tai
2 Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan (ROC).|3 Student Counseling Center, National Defense Medical Center, Taipei, Taiwan (ROC).
Hsin-An
HA
Chang
2 Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan (ROC).|3 Student Counseling Center, National Defense Medical Center, Taipei, Taiwan (ROC).|4 Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Song-Shan Branch, Taipei, Taiwan (ROC).
Yu-Chen
YC
Kao
2 Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan (ROC).|4 Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Song-Shan Branch, Taipei, Taiwan (ROC).
Nian-Sheng
NS
Tzeng
D000328:Adult; D018692:Antimanic Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D000068180:Aripiprazole / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D022124:Hyperammonemia / Q000139:chemically induced*; D007010:Hyponatremia / Q000139:chemically induced*; D014635:Valproic Acid / Q000009:adverse effects*
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D014635:Valproic Acid; D000068180:Aripiprazole